ITTO20020406A1 - Formulazioni di bisfosfonati ad uso iniettabile. - Google Patents

Formulazioni di bisfosfonati ad uso iniettabile.

Info

Publication number
ITTO20020406A1
ITTO20020406A1 IT2002TO000406A ITTO20020406A ITTO20020406A1 IT TO20020406 A1 ITTO20020406 A1 IT TO20020406A1 IT 2002TO000406 A IT2002TO000406 A IT 2002TO000406A IT TO20020406 A ITTO20020406 A IT TO20020406A IT TO20020406 A1 ITTO20020406 A1 IT TO20020406A1
Authority
IT
Italy
Prior art keywords
bisphosphonates
formulations
injectable use
injectable
Prior art date
Application number
IT2002TO000406A
Other languages
English (en)
Inventor
Andrea Capocchi
Rossella Musa
Raschini Annamaria Soliani
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27639074&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ITTO20020406(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Priority to IT2002TO000406A priority Critical patent/ITTO20020406A1/it
Publication of ITTO20020406A0 publication Critical patent/ITTO20020406A0/it
Priority to PE2003000440A priority patent/PE20040193A1/es
Priority to AU2003240225A priority patent/AU2003240225A1/en
Priority to PCT/EP2003/004934 priority patent/WO2003094925A1/en
Priority to ARP030101639A priority patent/AR040001A1/es
Publication of ITTO20020406A1 publication Critical patent/ITTO20020406A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT2002TO000406A 2002-05-13 2002-05-13 Formulazioni di bisfosfonati ad uso iniettabile. ITTO20020406A1 (it)

Priority Applications (5)

Application Number Priority Date Filing Date Title
IT2002TO000406A ITTO20020406A1 (it) 2002-05-13 2002-05-13 Formulazioni di bisfosfonati ad uso iniettabile.
PE2003000440A PE20040193A1 (es) 2002-05-13 2003-05-06 Formulaciones inyectables de bifosfonatos
AU2003240225A AU2003240225A1 (en) 2002-05-13 2003-05-12 Injectable bisphosphonate formulations
PCT/EP2003/004934 WO2003094925A1 (en) 2002-05-13 2003-05-12 Injectable bisphosphonate formulations
ARP030101639A AR040001A1 (es) 2002-05-13 2003-05-12 Formulaciones de bisfosfonatos de uso inyectable

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2002TO000406A ITTO20020406A1 (it) 2002-05-13 2002-05-13 Formulazioni di bisfosfonati ad uso iniettabile.

Publications (2)

Publication Number Publication Date
ITTO20020406A0 ITTO20020406A0 (it) 2002-05-13
ITTO20020406A1 true ITTO20020406A1 (it) 2003-11-13

Family

ID=27639074

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2002TO000406A ITTO20020406A1 (it) 2002-05-13 2002-05-13 Formulazioni di bisfosfonati ad uso iniettabile.

Country Status (5)

Country Link
AR (1) AR040001A1 (it)
AU (1) AU2003240225A1 (it)
IT (1) ITTO20020406A1 (it)
PE (1) PE20040193A1 (it)
WO (1) WO2003094925A1 (it)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006012700A1 (en) * 2004-08-04 2006-02-09 Team Health Pty Ltd Method of treatment

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1187828B (it) * 1985-05-24 1987-12-23 Gentili Ist Spa Composizione farmaceutica a base di difosfonati per il trattamento dell aretrosi
US5462932A (en) * 1994-05-17 1995-10-31 Merck & Co., Inc. Oral liquid alendronate formulations
IT1296495B1 (it) * 1997-11-21 1999-06-25 Prodotti Antibiotici Spa Impiego di bisfosfonati nella preparazione di forme farmaceutiche per somministrazione intramuscolare
US6677320B2 (en) * 2000-01-20 2004-01-13 Hoffmann-La Roches Inc. Parenteral bisphosphonate composition with improved local tolerance
EP1136069A1 (en) * 2000-03-21 2001-09-26 SPA SOCIETA' PRODOTTI ANTIBIOTICI S.p.A. Pharmaceutical compositions containing clodronates for high local tolerance intramuscular administration

Also Published As

Publication number Publication date
PE20040193A1 (es) 2004-05-31
AU2003240225A1 (en) 2003-11-11
AR040001A1 (es) 2005-03-09
ITTO20020406A0 (it) 2002-05-13
WO2003094925A1 (en) 2003-11-20

Similar Documents

Publication Publication Date Title
DK3536344T3 (da) Superfin formoterolformulering
PT1501534E (pt) Formulacoes farmaceuticas
EP1653935A4 (en) INFLAMMATORY FORMULATIONS
FI20031156A0 (fi) Liotusmenetelmä
NO20052306D0 (no) Dispergerbare farmasoytiske blandinger.
DE10328828A8 (de) Vermessungssystem
DK1670440T3 (da) HRT formuleringer
ITRM20040015A1 (it) Procedimento per la composizione di un rivestimento nanocomposito.
DE60315514D1 (de) Hochdosierte ibandronat-formulierung
IS8309A (is) Lyfjablöndur
EP1692279A4 (en) VIRUS PREPARATIONS CONTAINING A CONSERVATIVE
ITMI20022022A1 (it) Analoghi di nocicettina.
DE60333672D1 (de) Sprühbare ölartige formulierungen
EP1490040A4 (en) INFLAMMATORY FORMULATIONS
ATE535775T1 (de) Präzisionsdendrometer
ITMI20032175A1 (it) Formulazioni farmaceutiche di bisfosfonati destinate
DE10390373D2 (de) Phosphorchelatverbindungen
ITMC20040073A1 (it) Attrezzatura di connessione meccanica ad uso implantologico.
ITMI20030479A1 (it) Procedimento per la preparazione di un ciano-isobenzofurano.
ITMI20031994A1 (it) Procedimento per la preparazione di fludarabina fosfato
ITTO20020406A1 (it) Formulazioni di bisfosfonati ad uso iniettabile.
ITBO20030521A1 (it) Endoscopio per uso oculistico.
ITMI20030352A1 (it) Metodo per la sintesi di metiltriossorenio.
ITTO20020465A0 (it) Procedimento per la preparazione di doxofillina.
ITVA20020048A1 (it) Procedimento per la realizzazione di componenti di